497K 1 d854619d497k.htm EQ/T. ROWE PRICE HEALTH SCIENCES PORTFOLIO EQ/T. Rowe Price Health Sciences Portfolio

EQ ADVISORS TRUSTSM

 

EQ/Large Cap Growth Managed Volatility Portfolio

EQ/T. Rowe Price Health Sciences Portfolio

 

SUPPLEMENT DATED MARCH 31, 2025 TO THE SUMMARY PROSPECTUS, PROSPECTUS AND STATEMENT OF ADDITIONAL INFORMATION DATED MAY 1, 2024, AS SUPPLEMENTED

 

 

 

This Supplement updates certain information contained in the Summary Prospectus, Prospectus and Statement of Additional Information (“SAI”) of EQ Advisors Trust (“Trust”) dated May 1, 2024, as supplemented. You should read this Supplement in conjunction with the Summary Prospectus, Prospectus and SAI and retain it for future reference. You may view, print, and download these documents, free of charge, at the Trust’s website at https://equitable-funds.com.

 

The purpose of this Supplement is to provide you with information regarding changes to the portfolio managers for the EQ/Large Cap Growth Managed Volatility Portfolio and the EQ/T. Rowe Price Health Sciences Portfolio:

 

Effective March 31, 2025, Brandon Ladoff of Polen Capital Management, LLC no longer serves as a member of the team that is responsible for the securities selection, research and trading for a portion of the Active Allocated Portion of the EQ/Large Cap Growth Managed Volatility Portfolio. All references to Brandon Ladoff in the Summary Prospectus, Prospectus and SAI are deleted in their entirety.

 

*****

 

Effective March 31, 2025, the section of the SAI entitled “Appendix B — EQ Advisors Trust — Portfolio Manager Information – T. Rowe Price Associates, Inc.” is amended to include the following information:

 

 
T. Rowe Price Associates, Inc. (“T. Rowe Price” or “Sub-Adviser”)
     
Portfolio Manager   Presented below for each portfolio manager is the
number of other accounts managed by the portfolio
manager and the total assets in the accounts
managed within each category as of February 28,
2025
  Presented below for each of the categories is the
number of accounts and the total assets in the
accounts with respect to which the advisory fee is
based on the performance of the account
    Registered Investment Companies   Other Pooled Investment Vehicles   Other Accounts   Registered Investment Companies   Other Pooled Investment Vehicles   Other Accounts
    Number
of
Accounts
  Total

Assets

  Number
of
Accounts
  Total
Assets
  Number
of
Accounts
  Total

Assets

  Number
of
Accounts
  Total

Assets

  Number
of
Accounts
  Total
Assets
  Number
of
Accounts
  Total
Assets
 
EQ/T. Rowe Price Health Sciences Portfolio

Jason Nogueira

  7   $37.93B   40   $53.03B   8   $10.57B   0   N/A   0   N/A   0   N/A

 

Ownership of Shares of the Portfolio as of February 28, 2025

 

Portfolio Manager

  None   $1-

$10,000

  $10,001-

$50,000

  $50,001-

$100,000

  $100,001-

$500,000

  $500,001-

$1,000,000

  over

$1,000,000

 
EQ/T. Rowe Price Health Sciences Portfolio

Jason Nogueira

  X